Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

Share Price is delayed by 15 minutes
Get Live Data
308.00    0.00 (0.00%)
Bid:
292.00
Ask:
305.00
Spread: 13.00 (4.452%)
Market Cap: £163.24m
MAJE Live PriceLast checked at - London Stock Exchange

Intraday Majedie Inv. Share Chart

Final Net Asset Value

25 Mar 2026 14:41

RNS Number : 1311Y
Majedie Investments PLC
25 March 2026
 

 

 

Majedie Investments PLC

 

Legal Entity Identifier: 2138007QEY9DYONC2723

 

25 March 2026

 

Final Net Asset Value (NAV)

 

The unaudited net asset value estimate per share at the close of business on 28 February 2026 is:

 

326.09 pence per share

 

 

The net asset value published is on a cum-income basis, ex the Q1 2026 interim dividend of 2.30p per share, and is calculated on 52,998,795 ordinary shares, being the number of shares in issue.

 

 

 

Enquiries

Juniper Partners

Company Secretary

Ph: 0131 378 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVPPUUCWUPQGCA
Date   Source Headline
25th Mar 20245:10 pmRNSMid-Month Estimated Net Asset Value
12th Mar 202410:08 amRNSDirectorate Change
11th Mar 20245:39 pmRNSEstimated Net Asset Value
1st Mar 20242:48 pmRNSTotal Voting Rights
26th Feb 20246:15 pmRNSNet Asset Value(s)
26th Feb 20246:15 pmRNSNet Asset Value(s)
22nd Feb 20245:11 pmRNSHolding(s) in Company
1st Feb 202411:11 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSDividend Declaration
25th Jan 20245:52 pmRNSNet Asset Value(s)
25th Jan 20245:52 pmRNSNet Asset Value(s)
18th Jan 202412:46 pmRNSDirector Declaration
17th Jan 20244:17 pmRNSResult of AGM
10th Jan 202412:58 pmRNSNet Asset Value(s)
4th Jan 20242:30 pmRNSHolding(s) in Company
2nd Jan 20243:50 pmRNSResults analysis from Kepler Trust Intelligence
2nd Jan 202412:59 pmRNSTotal Voting Rights
22nd Dec 202312:42 pmRNSNet Asset Value(s)
22nd Dec 202312:41 pmRNSNet Asset Value(s)
18th Dec 20234:06 pmRNSBlock listing Interim Review
18th Dec 20237:00 amRNSAnnual Financial Report
11th Dec 20235:36 pmRNSNet Asset Value(s)
1st Dec 202311:47 amRNSTotal Voting Rights
27th Nov 20232:44 pmRNSNet Asset Value(s)
24th Nov 20235:19 pmRNSNet Asset Value(s)
17th Nov 20234:56 pmRNSHolding(s) in Company
10th Nov 20233:35 pmRNSNet Asset Value(s)
8th Nov 20237:05 amRNSBoard role change
8th Nov 20237:00 amRNSDividend Declaration
1st Nov 202310:42 amRNSTotal Voting Rights
25th Oct 20236:25 pmRNSNet Asset Value(s)
25th Oct 20236:25 pmRNSNet Asset Value(s)
10th Oct 20235:53 pmRNSNet Asset Value(s)
2nd Oct 202311:32 amRNSTotal Voting Rights
25th Sep 20235:14 pmRNSNet Asset Value(s)
25th Sep 20235:13 pmRNSNet Asset Value(s)
11th Sep 20235:45 pmRNSNet Asset Value(s)
1st Sep 202311:42 amRNSTotal Voting Rights
30th Aug 202312:59 pmRNSHolding(s) in Company
25th Aug 202312:59 pmRNSNet Asset Value(s)
25th Aug 202312:58 pmRNSNet Asset Value(s)
10th Aug 20236:13 pmRNSNet Asset Value(s)
2nd Aug 20237:00 amRNSDividend Declaration
1st Aug 20234:12 pmRNSTotal Voting Rights
28th Jul 202311:52 amRNSDirector/PDMR Shareholding
25th Jul 202312:30 pmRNSNet Asset Value(s)
25th Jul 202312:29 pmRNSNet Asset Value(s)
10th Jul 20236:14 pmRNSNet Asset Value(s)
3rd Jul 202311:30 amRNSTotal Voting Rights
26th Jun 20236:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.